Skip to main content
Erschienen in: Obesity Surgery 6/2016

29.09.2015 | Original Contributions

The Effect of Intraoperative N-Acetylcysteine on Hepatocellular Injury During Laparoscopic Bariatric Surgery. A Randomised Controlled Trial

verfasst von: Ajay P. Belgaumkar, Kirstin A. Carswell, Robin D. Hughes, Alberto Quaglia, Anil Dhawan, Ragai R. Mitry, Ameet G. Patel

Erschienen in: Obesity Surgery | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

The combination of pneumoperitoneum and intraoperative retraction of the left lobe of the liver leads to hepatocellular injury during laparoscopic gastric surgery. Fatty livers are more susceptible to ischaemic insults. This trial investigated whether the antioxidant N-acetylcysteine (NAC) reduced liver injury during laparoscopic sleeve gastrectomy (LSG).

Methods

Patients undergoing LSG were randomised (single blinded) to receive intraoperative NAC infusion or standard anaesthetic treatment. Blood samples were taken before and after surgery (days 0 to 4). Primary endpoints included serum aminotransferases. Secondary measures were C-reactive protein, weight cell count (WCC), cytokines (interleukin 6 and 10) and cytokeratin-18 as markers of apoptosis. Intraoperative liver biopsy samples were assessed using a locally developed injury score.

Results

Twenty patients (14 females, mean age 44.5 (SEM ± 2.9) years, mean BMI 60.8 (SEM ± 2.4) kg/m2) were recruited (NAC n = 10, control n = 10). The trial was stopped early after a planned interim analysis. Baseline liver function was similar. The peak rise in liver enzymes was on day 1, but levels were not significantly different between the groups. Rates of complications and length of stay were not significantly different. Secondary outcome measures, including white cell count (WCC), cytokines and cytokeratin (CK)-18 fragments, were not different between groups. Liver injury scores did not differ significantly.

Conclusions

NAC did not reduce intraoperative liver injury in this small number of patients. The heterogenous nature of the study population, with differences in co-morbidities, body mass index and intraabdominal anatomy, leads to a varied post-operative inflammatory response. Significant hepatocyte injury occurs through both necrosis and apoptosis.
Literatur
1.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA: J Am Med Assoc. 2004;292:1724–37.CrossRef Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA: J Am Med Assoc. 2004;292:1724–37.CrossRef
2.
Zurück zum Zitat Nguyen NT, Braley S, Fleming NW, et al. Comparison of postoperative hepatic function after laparoscopic versus open gastric bypass. Am J Surg. 2003;186:40–4.CrossRefPubMed Nguyen NT, Braley S, Fleming NW, et al. Comparison of postoperative hepatic function after laparoscopic versus open gastric bypass. Am J Surg. 2003;186:40–4.CrossRefPubMed
3.
Zurück zum Zitat Brolin RE, Bradley LJ, Taliwal RV. Unsuspected cirrhosis discovered during elective obesity operations. Arch Surg. 1998;133:84–8.CrossRefPubMed Brolin RE, Bradley LJ, Taliwal RV. Unsuspected cirrhosis discovered during elective obesity operations. Arch Surg. 1998;133:84–8.CrossRefPubMed
4.
Zurück zum Zitat Cotler SJ, Vitello JM, Guzman G, et al. Hepatic decompensation after gastric bypass surgery for severe obesity. Dig Dis Sci. 2004;49:1563–8.CrossRefPubMed Cotler SJ, Vitello JM, Guzman G, et al. Hepatic decompensation after gastric bypass surgery for severe obesity. Dig Dis Sci. 2004;49:1563–8.CrossRefPubMed
5.
Zurück zum Zitat Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol: Off Clin Prac J Am Gastroenterol Assoc. 2008;6:1396–402.CrossRef Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol: Off Clin Prac J Am Gastroenterol Assoc. 2008;6:1396–402.CrossRef
7.
Zurück zum Zitat Mehta K, Van Thiel DH, Shah N, et al. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev. 2002;60:289–93.CrossRefPubMed Mehta K, Van Thiel DH, Shah N, et al. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev. 2002;60:289–93.CrossRefPubMed
8.
Zurück zum Zitat Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol. 2007;35:757–66.CrossRefPubMed Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol. 2007;35:757–66.CrossRefPubMed
9.
Zurück zum Zitat Swain SD, Rohn TT, Quinn MT. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid Redox Signal. 2002;4:69–83.CrossRefPubMed Swain SD, Rohn TT, Quinn MT. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid Redox Signal. 2002;4:69–83.CrossRefPubMed
10.
Zurück zum Zitat Tashiro H, Kuroda S, Mikuriya Y, Ohdan H (2013) Ischemia-reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery. Surgery Today Tashiro H, Kuroda S, Mikuriya Y, Ohdan H (2013) Ischemia-reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery. Surgery Today
11.
Zurück zum Zitat Selzner M, Rudiger HA, Sindram D, et al. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology. 2000;32:1280–8.CrossRefPubMed Selzner M, Rudiger HA, Sindram D, et al. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology. 2000;32:1280–8.CrossRefPubMed
12.
Zurück zum Zitat Whitehead JP, Richards AA, Hickman IJ, et al. Adiponectin—a key adipokine in the metabolic syndrome. Diabetes, Obes Metab. 2006;8:264–80.CrossRef Whitehead JP, Richards AA, Hickman IJ, et al. Adiponectin—a key adipokine in the metabolic syndrome. Diabetes, Obes Metab. 2006;8:264–80.CrossRef
13.
Zurück zum Zitat Jimenez-Castro MB, Casillas-Ramirez A, Mendes-Braz M, et al. Adiponectin and resistin protect steatotic livers undergoing transplantation. J Hepatol. 2013;59:1208–14.CrossRefPubMed Jimenez-Castro MB, Casillas-Ramirez A, Mendes-Braz M, et al. Adiponectin and resistin protect steatotic livers undergoing transplantation. J Hepatol. 2013;59:1208–14.CrossRefPubMed
14.
Zurück zum Zitat McKay A, Cassidy D, Sutherland F, et al. Clinical results of N-acetylcysteine after major hepatic surgery: a review. J Hepato-Biliary-Pancreat Surg. 2008;15:473–8.CrossRef McKay A, Cassidy D, Sutherland F, et al. Clinical results of N-acetylcysteine after major hepatic surgery: a review. J Hepato-Biliary-Pancreat Surg. 2008;15:473–8.CrossRef
15.
Zurück zum Zitat Jegatheeswaran S, Siriwardena AK. Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery. HPB: Off J Int Hepato Pancreato Biliary Assoc. 2011;13:71–8.CrossRef Jegatheeswaran S, Siriwardena AK. Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery. HPB: Off J Int Hepato Pancreato Biliary Assoc. 2011;13:71–8.CrossRef
16.
Zurück zum Zitat Robinson SM, Saif R, Sen G, et al. N-acetylcysteine administration does not improve patient outcome after liver resection. HPB: Off J Int Hepato Pancreato Biliary Assoc. 2013;15:457–62.CrossRef Robinson SM, Saif R, Sen G, et al. N-acetylcysteine administration does not improve patient outcome after liver resection. HPB: Off J Int Hepato Pancreato Biliary Assoc. 2013;15:457–62.CrossRef
17.
Zurück zum Zitat Owen-Smith A, Kipping R, Donovan J, et al. A NICE example? Variation in provision of bariatric surgery in England. BMJ. 2013;346:f2453.CrossRefPubMed Owen-Smith A, Kipping R, Donovan J, et al. A NICE example? Variation in provision of bariatric surgery in England. BMJ. 2013;346:f2453.CrossRefPubMed
18.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.CrossRefPubMed Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.CrossRefPubMed
19.
Zurück zum Zitat Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.CrossRefPubMedPubMedCentral Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Sagias FG, Mitry RR, Hughes RD, et al. N-acetylcysteine improves the viability of human hepatocytes isolated from severely steatotic donor liver tissue. Cell Transplant. 2010;19:1487–92.CrossRefPubMed Sagias FG, Mitry RR, Hughes RD, et al. N-acetylcysteine improves the viability of human hepatocytes isolated from severely steatotic donor liver tissue. Cell Transplant. 2010;19:1487–92.CrossRefPubMed
23.
Zurück zum Zitat Sammour T, Mittal A, Loveday BP, et al. Systematic review of oxidative stress associated with pneumoperitoneum. Br J Surg. 2009;96:836–50.CrossRefPubMed Sammour T, Mittal A, Loveday BP, et al. Systematic review of oxidative stress associated with pneumoperitoneum. Br J Surg. 2009;96:836–50.CrossRefPubMed
24.
Zurück zum Zitat Nguyen NT, Goldman CD, Ho HS, et al. Systemic stress response after laparoscopic and open gastric bypass. J Am Coll Surg. 2002;194:557–66. discussion 566–557.CrossRefPubMed Nguyen NT, Goldman CD, Ho HS, et al. Systemic stress response after laparoscopic and open gastric bypass. J Am Coll Surg. 2002;194:557–66. discussion 566–557.CrossRefPubMed
25.
Zurück zum Zitat Sanni A, Perez S, Medbery R, et al. Postoperative complications in bariatric surgery using age and BMI stratification: a study using ACS-NSQIP data. Surg Endosc. 2014;28:3302–9.CrossRefPubMed Sanni A, Perez S, Medbery R, et al. Postoperative complications in bariatric surgery using age and BMI stratification: a study using ACS-NSQIP data. Surg Endosc. 2014;28:3302–9.CrossRefPubMed
26.
Zurück zum Zitat Rao SR. Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm Res: Off J Eur Histamine Res Soc. 2012;61:789–807.CrossRef Rao SR. Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm Res: Off J Eur Histamine Res Soc. 2012;61:789–807.CrossRef
27.
Zurück zum Zitat Jacobi CA, Wenger F, Opitz I, et al. Immunologic changes during minimally invasive surgery. Dig Surg. 2002;19:459–63.CrossRefPubMed Jacobi CA, Wenger F, Opitz I, et al. Immunologic changes during minimally invasive surgery. Dig Surg. 2002;19:459–63.CrossRefPubMed
28.
Zurück zum Zitat Fontana L, Eagon JC, Trujillo ME, et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010–3.CrossRefPubMed Fontana L, Eagon JC, Trujillo ME, et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010–3.CrossRefPubMed
29.
Zurück zum Zitat Dalmas E, Rouault C, Abdennour M, et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr. 2011;94:450–8.CrossRefPubMed Dalmas E, Rouault C, Abdennour M, et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr. 2011;94:450–8.CrossRefPubMed
30.
Zurück zum Zitat Rabelo F, Oliveira CP, Faintuch J, et al. Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis. Obes Surg. 2010;20:906–12.CrossRefPubMed Rabelo F, Oliveira CP, Faintuch J, et al. Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis. Obes Surg. 2010;20:906–12.CrossRefPubMed
31.
Zurück zum Zitat Dali-Youcef N, Mecili M, Ricci R, et al. Metabolic inflammation: connecting obesity and insulin resistance. Ann Med. 2013;45:242–53.CrossRefPubMed Dali-Youcef N, Mecili M, Ricci R, et al. Metabolic inflammation: connecting obesity and insulin resistance. Ann Med. 2013;45:242–53.CrossRefPubMed
32.
Zurück zum Zitat Behnes M, Brueckmann M, Lang S, et al. Alterations of adiponectin in the course of inflammation and severe sepsis. Shock. 2012;38:243–8.CrossRefPubMed Behnes M, Brueckmann M, Lang S, et al. Alterations of adiponectin in the course of inflammation and severe sepsis. Shock. 2012;38:243–8.CrossRefPubMed
33.
Zurück zum Zitat Bieghs V, Trautwein C. Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2014;3:377–85.PubMedPubMedCentral Bieghs V, Trautwein C. Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2014;3:377–85.PubMedPubMedCentral
34.
Zurück zum Zitat Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1083–8.CrossRefPubMed Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1083–8.CrossRefPubMed
35.
Zurück zum Zitat Hutchins NA, Unsinger J, Hotchkiss RS, et al. The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med. 2014;20:224–33.CrossRefPubMedPubMedCentral Hutchins NA, Unsinger J, Hotchkiss RS, et al. The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med. 2014;20:224–33.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Kahraman A, Sowa JP, Schlattjan M, et al. Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients. Clin Sci. 2013;125:391–400.CrossRefPubMed Kahraman A, Sowa JP, Schlattjan M, et al. Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients. Clin Sci. 2013;125:391–400.CrossRefPubMed
37.
Zurück zum Zitat Geng Q, Ren J, Chen H, et al. Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials. Clin Exp Pharmacol Physiol. 2013;40:219–26.CrossRefPubMed Geng Q, Ren J, Chen H, et al. Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials. Clin Exp Pharmacol Physiol. 2013;40:219–26.CrossRefPubMed
38.
Zurück zum Zitat Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, et al. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008;147:153–9.CrossRefPubMedPubMedCentral Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, et al. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008;147:153–9.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Fusai G, Glantzounis GK, Hafez T, et al. N-acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis. Clin Sci. 2005;109:465–73.CrossRefPubMed Fusai G, Glantzounis GK, Hafez T, et al. N-acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis. Clin Sci. 2005;109:465–73.CrossRefPubMed
Metadaten
Titel
The Effect of Intraoperative N-Acetylcysteine on Hepatocellular Injury During Laparoscopic Bariatric Surgery. A Randomised Controlled Trial
verfasst von
Ajay P. Belgaumkar
Kirstin A. Carswell
Robin D. Hughes
Alberto Quaglia
Anil Dhawan
Ragai R. Mitry
Ameet G. Patel
Publikationsdatum
29.09.2015
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 6/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1904-3

Weitere Artikel der Ausgabe 6/2016

Obesity Surgery 6/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.